Harrow (HROW) Shares Outstanding (2010 - 2026)

Harrow's (HROW) quarterly Shares Outstanding (Entity) came in at $37.3 million in Q1 2026, up 4.53% year-on-year from $35.7 million in Q1 2025, and little changed quarter-over-quarter from $37.2 million in Q4 2025.

Harrow (HROW) Shares Outstanding (2010 - 2026) Analysis & Trends

Harrow's Shares Outstanding (Entity) history runs 15 years deep, the most recent figure standing at $37.3 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Entity) rose 4.53% year-over-year to $37.3 million in Q1 2026; TTM through Mar 2026 was $37.3 million, a 4.53% increase from a year earlier, with the FY2025 full-year figure at $37.2 million, up 4.51% from the prior year.
  • Shares Outstanding (Entity) steadied at $37.3 million in Q1 2026 per HROW's latest filing, from $37.2 million in the prior quarter.
  • Across five years, Shares Outstanding (Entity) topped out at $37.3 million in Q1 2026 and bottomed at $27.0 million in Q1 2022.
  • The 5-year median for Shares Outstanding (Entity) is $35.4 million (2024), against an average of $33.4 million.
  • Across the five-year window, Shares Outstanding (Entity) climbed 0.64% in 2022 and climbed 29.71% in 2023, its largest moves.
  • Year by year, Shares Outstanding (Entity) stood at $29.9 million in 2022, then grew by 17.61% to $35.2 million in 2023, then advanced by 1.29% to $35.6 million in 2024, then grew by 4.51% to $37.2 million in 2025, then climbed by 0.11% to $37.3 million in 2026.
  • Per Business Quant, the three latest HROW Shares Outstanding (Entity) figures stand at $37.3 million (Q1 2026), $37.2 million (Q4 2025), and $37.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - 8.98 Bn
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn 1.16 Bn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 422.10 Mn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn 1.58 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn 43.50 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - 31.59 Bn
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 1.16 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 100.50 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn 497.70 Mn
10 Harrow 1.43 Bn 1.34 Bn 27.05 Mn 37.23 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 37.23 Mn
Dec 31, 2025 36.76 Mn
Sep 30, 2025 37.15 Mn
Jun 30, 2025 36.79 Mn
Mar 31, 2025 35.83 Mn
Dec 31, 2024 35.65 Mn
Sep 30, 2024 35.70 Mn
Jun 30, 2024 35.62 Mn
Mar 31, 2024 35.47 Mn
Dec 31, 2023 32.62 Mn
Sep 30, 2023 34.26 Mn
Jun 30, 2023 30.46 Mn
Mar 31, 2023 30.29 Mn
Dec 31, 2022 27.46 Mn
Sep 30, 2022 27.35 Mn
Jun 30, 2022 27.30 Mn
Mar 31, 2022 27.23 Mn
Dec 31, 2021 26.76 Mn
Sep 30, 2021 27.11 Mn
Jun 30, 2021 26.74 Mn